US BANCORP \DE\ - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,106
-3.9%
2,557
+50.6%
0.00%
Q2 2023$8,439
+250.0%
1,698
+248.0%
0.00%
Q1 2023$2,411
-88.5%
488
-85.3%
0.00%
Q4 2022$20,946
-61.2%
3,330
-32.4%
0.00%
Q3 2022$54,000
-14.3%
4,923
-10.1%
0.00%
Q2 2022$63,000
+80.0%
5,474
+41.9%
0.00%
Q1 2022$35,000
-16.7%
3,858
+35.5%
0.00%
Q4 2021$42,000
+200.0%
2,848
+420.7%
0.00%
Q3 2021$14,000
-94.8%
547
-94.7%
0.00%
-100.0%
Q2 2021$271,000
-26.0%
10,410
+0.4%
0.00%0.0%
Q1 2021$366,000
+5128.6%
10,368
+3390.9%
0.00%
Q4 2020$7,000
+250.0%
297
+494.0%
0.00%
Q3 2020$2,000
-33.3%
50
-31.5%
0.00%
Q2 2020$3,000
+200.0%
73
+46.0%
0.00%
Q1 2020$1,0000.0%500.0%0.00%
Q4 2019$1,0000.0%500.0%0.00%
Q3 2019$1,000500.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders